Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis

Br J Dermatol. 2020 Aug;183(2):376-378. doi: 10.1111/bjd.18941. Epub 2020 Mar 20.

Authors

E Chambrelan^{1

2}, S Barbarot³, L Bekel⁴, F Poizeau^{1

2

5}, E Mahé, E Puzenat, J Delaunay, S Mallet, D Bessis, A Maruani, J Miquel, N Raison-Peyron, C Abasq, A Phan, A Du Thanh, I Kupfer, B Bonniaud, G Bouzille, A Dupuy^{1

2

5}, C Droitcourt^{1

2

5}; Groupe de Recherche sur l'Eczéma Atopique de la Société Française de Dermatologie (GREAT) and Société Française de Dermatologie Pédiatrique (SFDP)

Affiliations

¹ Department of Dermatology, CHU Rennes, F35000, Rennes, France.
² University of Rennes 1, F35000, Rennes, France.
³ Department of Dermatology, CHU Nantes, F44093, Nantes, France.
⁴ Department of Dermatology and Pediatric Dermatology, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), F75015, Paris, France.
⁵ EA 7449 REPERES Pharmacoepidemiology and Health Services Research, F35000, Rennes, France.

PMID: 32037515
DOI: 10.1111/bjd.18941

No abstract available

Publication types

Letter

MeSH terms

Child
Cohort Studies
Cyclosporine
Dermatitis, Atopic* / drug therapy
Eczema*
Humans
Pharmaceutical Preparations*

Substances

Pharmaceutical Preparations
Cyclosporine